EUVIMEDEUVIMED entdecken
Open Access · CC BY 4.0

Proteome Alterations in Cardiac Fibroblasts: Insights from Experimental Myocardial Infarction and Clinical Ischaemic Cardiomyopathy

Adam Russell-Hallinan iD, Claire Tonry, Lauren Kerrigan iD, Kevin Edgar, Patrick Collier iD, Ken McDonald, Mark Ledwidge, David Grieve, Narainrit Karuna iD, Chris Watson iD

International Journal of Molecular Sciences · 2025

DOI: 10.3390/ijms26083846 ↗

Kurz gefasst

Fachartikel in der Zeitschrift International Journal of Molecular Sciences, 2025. Verfasst von Adam Russell-Hallinan und 9 weiteren Autor:innen. Beteiligte Einrichtung: Wellcome-Wolfson Institute for Experimental Medicine, Queen's University Belfast, Belfast BT9 7BL, Northern Ireland, UK. Hauptthemen laut MEDLINE: Fibroblasts, Myocardial Infarction, Proteome, Myocardium. Die Arbeit wurde bisher 1-mal zitiert (Crossref) und nennt 59 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0). Gefördert von: British Heart Foundation, Heart Research UK, European Society of Cardiology (ESC) First Contact Initiative Grant.

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Ischaemic heart disease (IHD) is a chronic condition that can cause pathological cardiac remodelling and heart failure (HF). In this study, we sought to determine how cardiac fibroblasts were altered post-experimental myocardial infarction (MI). Female C57BL6 mice underwent experimental MI by permanent left coronary artery ligation. Cardiac fibroblasts were isolated from extracted heart tissue of experimental MI mice and subsequently treated with the pro-fibrotic cytokine, TGF-β, for 24 h and analysed using high throughput LC-MS/MS analysis. Findings were validated using mass spectrometry data generated from human left ventricular tissue analysis, which were collected from patients with ischaemic cardiomyopathy (ISCM) and age/sex-matched patients without clinical HF (NF). Proteomic analysis revealed significant protein expression changes in mouse cardiac fibroblasts after MI. These changes were most pronounced at 1 month post-MI, compared to earlier time points (3 days and 1 week). TGF-β treatment profoundly affected fibroblast cells extracted from MI mice, indicating a heightened sensitivity to pro-fibrotic factors after myocardial injury. Extracellular matrix (ECM) proteins significantly altered in MI fibroblasts following TGF-β treatment were significantly associated with cardiac remodelling. Notably, Lox was significantly changed in both isolated fibroblasts treated with TGF-β from experiment MI mice and human ISCM. Isolated cardiac fibroblasts from MI mice are more susceptible to developing pathogenic traits following TGF-β treatment than isolated fibroblasts from normal heart tissue. ECM proteins associated with these enhanced fibroblast activities and functions are evident. These altered proteins may play a functional role in MI-associated cardiac dysfunction.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

FibroblastsMyocardial InfarctionProteomeMyocardiumCardiomyopathiesMyocardial IschemiaAnimalsHumansMiceFemaleMice, Inbred C57BLTransforming Growth Factor betaProteomicsDisease Models, AnimalVentricular Remodeling

Stichwörter der Autor:innen

TGF-βcardiac remodellingextracellular matrixischaemic heart diseasemyocardial infarctionproteomics

Substanzen

ProteomeTransforming Growth Factor beta

Autor:innen und Institutionen

  • Wellcome-Wolfson Institute for Experimental Medicine, Queen's University Belfast, Belfast BT9 7BL, Northern Ireland, UK.
  • Department of Cardiovascular Medicine, Cleveland Clinic, Cleveland, OH 44195, USA.
  • STOP-HF Unit, St Vincent's University Hospital Healthcare Group, D04 T6F4 Dublin, Ireland.
  • UCD Conway Institute, School of Medicine, University College Dublin, D04 V1W8 Dublin, Ireland.
  • Department of Pharmaceutical Care, Faculty of Pharmacy, Chiang Mai University, Chiang Mai 50200, Thailand.

ORCID-Profile: Adam Russell-Hallinan, Lauren Kerrigan, Patrick Collier, Narainrit Karuna, Chris Watson

Förderung

  • British Heart Foundation
  • Heart Research UK
  • European Society of Cardiology (ESC) First Contact Initiative Grant

Zitieren

APA

Russell-Hallinan, A., Tonry, C., Kerrigan, L., Edgar, K., Collier, P., McDonald, K., Ledwidge, M., Grieve, D., Karuna, N., & Watson, C. (2025). Proteome Alterations in Cardiac Fibroblasts: Insights from Experimental Myocardial Infarction and Clinical Ischaemic Cardiomyopathy. International Journal of Molecular Sciences. https://doi.org/10.3390/ijms26083846

Vancouver

Russell-Hallinan A, Tonry C, Kerrigan L, Edgar K, Collier P, McDonald K, et al. Proteome Alterations in Cardiac Fibroblasts: Insights from Experimental Myocardial Infarction and Clinical Ischaemic Cardiomyopathy. International Journal of Molecular Sciences. 2025. doi:10.3390/ijms26083846

BibTeX
@article{RussellHallinan2025,
  author = {Russell-Hallinan, Adam and Tonry, Claire and Kerrigan, Lauren and Edgar, Kevin and Collier, Patrick and McDonald, Ken and Ledwidge, Mark and Grieve, David and Karuna, Narainrit and Watson, Chris},
  title = {Proteome Alterations in Cardiac Fibroblasts: Insights from Experimental Myocardial Infarction and Clinical Ischaemic Cardiomyopathy},
  journal = {International Journal of Molecular Sciences},
  year = {2025},
  doi = {10.3390/ijms26083846}
}
Kostenlos starten →